΄
1. Characterization and Functional Analysis of Extracellular Vesicles
and Muscle-Abundant miRNAs (miR-1, miR-133a, and miR-206) in C2C12 Myocytes and
mdx Mice.
Matsuzaka Y, Tanihata J, Komaki H, Ishiyama A, Oya Y,
Rüegg U, Takeda SI, Hashido K.
PLoS One. 2016 Dec 15;11(12):e0167811. doi:
10.1371/journal.pone.0167811. eCollection 2016.
2. Basic fibroblast
growth factor induces miR-134 upregulation in astrocyte for cell maturation.
Numakawa T, Nakajima S, Yamamoto N, Ooshima Y, Odaka H, Hashido K, Adachi N,
Kunugi H.
Biochem Biophys Res Commun. 2015 Jan 2;456(1):465-70. doi:
10.1016/j.bbrc.2014.11.108. Epub 2014 Dec 4.
3. Three novel serum
biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy,
Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.
Matsuzaka Y, Kishi S, Aoki Y, Komaki H, Oya Y, Takeda S, Hashido K.
Environ
Health Prev Med. 2014 Nov;19(6):452-8. doi: 10.1007/s12199-014-0405-7. Epub 2014
Aug 24.
4. Impairments in brain-derived neurotrophic factor-induced
glutamate release in cultured cortical neurons derived from rats with
intrauterine growth retardation: possible involvement of suppression of
TrkB/phospholipase C-Α activation.
Numakawa T, Matsumoto T, Ooshima
Y, Chiba S, Furuta M, Izumi A, Ninomiya-Baba M, Odaka H, Hashido K, Adachi N,
Kunugi H.
Neurochem Res. 2014 Apr;39(4):785-92. doi:
10.1007/s11064-014-1270-x. Epub 2014 Mar 6.
5. Growth factors
stimulate expression of neuronal and glial miR-132.
Numakawa T, Yamamoto N,
Chiba S, Richards M, Ooshima Y, Kishi S, Hashido K, Adachi N, Kunugi H.
Neurosci Lett. 2011 Nov 21;505(3):242-7. doi: 10.1016/j.neulet.2011.10.025. Epub
2011 Oct 19.
6. Identification of muscle-specific microRNAs in serum
of muscular dystrophy animal models: promising novel blood-based markers for
muscular dystrophy.
Mizuno H, Nakamura A, Aoki Y, Ito N, Kishi S,
Yamamoto K, Sekiguchi M, Takeda S, Hashido K.
PLoS One. 2011 Mar
30;6(3):e18388. doi: 10.1371/journal.pone.0018388.
7. Glucocorticoid
attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate
receptors via the suppression of microRNA-132 expression.
Kawashima
H, Numakawa T, Kumamaru E, Adachi N, Mizuno H, Ninomiya M, Kunugi H, Hashido K.
Neuroscience. 2010 Feb 17;165(4):1301-11. doi:
10.1016/j.neuroscience.2009.11.057. Epub 2009 Dec 1.
ΰ
1. MicroRNA
function and neurotrophin BDNF.
Numakawa T, Richards M, Adachi N, Kishi S,
Kunugi H, Hashido K.
Neurochem Int. 2011 Oct;59(5):551-8. doi:
10.1016/j.neuint.2011.06.009. Epub 2011 Jun 24. Review.
2. RNA and disease,
2(2) 2015, http://dx.doi.org/10.14800/rd.558, Roles of miR-1, miR-133a, and
miR-206 in calcium, oxidative stress, and NO signaling involved in muscle
diseases@Yasunari Matsuzaka, Kazuo Hashido
ϊ{κΰ
1. ΧEHwAΧEHw@Vol.31
No.6@_oΑΩImicroRNAΖ_o`B
iΐμLCέ @κYC΄ΛavCχ _j